UAMS Myeloma Institute adds $166m to economy. (Health Care).
Housed in the Arkansas Cancer Research Center at UAMS, the Myeloma Institute is the world's largest center for the treatment of multiple myeloma, an uncommon form of cancer.
A study by the University of Arkansas at Little Rock's Institute for Economic Advancement said more than 1,600 patients are treated by the institute each year. Most of those patients are from outside of Arkansas, with an average of one person accompanying each patient. Combined, an average of 3,312 people come to Little Rock each year in conjunction with visits to the institute, usually staying three months.
The $166 million comprises $60.8 million for hospital activities, including salaries and items necessary for hospital functions; $81.6 million in direct expenditures by the staff and the institute, including $48.8 million spent on research and medical care; and $23.7 million in spin-off effects, including services and goods provided by vendors in response to the institute's activities.
"Our program continues to grow each year as word spreads about our success rate in treating myeloma. I am committed to staying at UAMS," Dr. Bart Barlogie, director of the Myeloma Institute, said in a news release. The program will soon move into the new Jackson T. Stephens Spine and Neurosciences Institute.
UAMS and its affiliates, Arkansas Children's Hospital and Central Arkansas Veterans Healthcare System, generate more than $1 billion of direct impact and more than $3 billion of indirect impact on the Arkansas economy, according to the Institute for Economic Advancement.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||University of Arkansas for Medical Sciences|
|Comment:||UAMS Myeloma Institute adds $166m to economy. (Health Care).(University of Arkansas for Medical Sciences )|
|Article Type:||Brief Article|
|Date:||Jun 9, 2003|
|Previous Article:||"Wealthy-friendly" states.|
|Next Article:||Deltic Timber names new CEO. (Forestry).|